Survival and disease complications in thalassemia major

Caterina Borgna-Pignatti, Simone Rugolotto, Piero De Stefano, Antonio Piga, Felicia Di Gregorio, Maria Rita Gamberini, Vincenzo Sabato, Caterina Melevendi, Maria Domenica Cappellini, Giuseppe Verlato

Research output: Contribution to journalArticle

247 Citations (Scopus)

Abstract

We studied survival and disease complications in 1146 patients with thalassemia major, born from January 1, 1960 to December 31, 1987. At last follow-up, in March 1997, probability of survival to age 20 years was 89% and to age 25 years was 82% for patients born in the years 1970-1974. Patients who died had a serum ferritin level, measured the year before death, significantly higher than those who survived. Diabetes was present in 5.4% of the patients; heart failure in 6.4%, arrhythmias in 5.0%, thrombosis in 1.1%, hypothyroidism in 11.6%, HIV infection in 1.8%. Hypogonadism was diagnosed in 55% of 578 patients who had reached pubertal age: 83.5% of hypogonadic females and 78.6% of males were receiving substitutive hormonal therapy. In conclusion, the survival of patients with thalassemia major is good and improving, but the prevalence of severe complications is still high.

Original languageEnglish
Pages (from-to)227-231
Number of pages5
JournalAnnals of the New York Academy of Sciences
Volume850
DOIs
Publication statusPublished - 1998

Fingerprint

beta-Thalassemia
Ferritins
Medical problems
Survival
Hypogonadism
Hypothyroidism
HIV Infections
Complications
Cardiac Arrhythmias
Thrombosis
Heart Failure
Serum

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Piga, A., Di Gregorio, F., Gamberini, M. R., ... Verlato, G. (1998). Survival and disease complications in thalassemia major. Annals of the New York Academy of Sciences, 850, 227-231. https://doi.org/10.1111/j.1749-6632.1998.tb10479.x

Survival and disease complications in thalassemia major. / Borgna-Pignatti, Caterina; Rugolotto, Simone; De Stefano, Piero; Piga, Antonio; Di Gregorio, Felicia; Gamberini, Maria Rita; Sabato, Vincenzo; Melevendi, Caterina; Cappellini, Maria Domenica; Verlato, Giuseppe.

In: Annals of the New York Academy of Sciences, Vol. 850, 1998, p. 227-231.

Research output: Contribution to journalArticle

Borgna-Pignatti, C, Rugolotto, S, De Stefano, P, Piga, A, Di Gregorio, F, Gamberini, MR, Sabato, V, Melevendi, C, Cappellini, MD & Verlato, G 1998, 'Survival and disease complications in thalassemia major', Annals of the New York Academy of Sciences, vol. 850, pp. 227-231. https://doi.org/10.1111/j.1749-6632.1998.tb10479.x
Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR et al. Survival and disease complications in thalassemia major. Annals of the New York Academy of Sciences. 1998;850:227-231. https://doi.org/10.1111/j.1749-6632.1998.tb10479.x
Borgna-Pignatti, Caterina ; Rugolotto, Simone ; De Stefano, Piero ; Piga, Antonio ; Di Gregorio, Felicia ; Gamberini, Maria Rita ; Sabato, Vincenzo ; Melevendi, Caterina ; Cappellini, Maria Domenica ; Verlato, Giuseppe. / Survival and disease complications in thalassemia major. In: Annals of the New York Academy of Sciences. 1998 ; Vol. 850. pp. 227-231.
@article{29a0bc63de224738ba93a6efb7bbc4ef,
title = "Survival and disease complications in thalassemia major",
abstract = "We studied survival and disease complications in 1146 patients with thalassemia major, born from January 1, 1960 to December 31, 1987. At last follow-up, in March 1997, probability of survival to age 20 years was 89{\%} and to age 25 years was 82{\%} for patients born in the years 1970-1974. Patients who died had a serum ferritin level, measured the year before death, significantly higher than those who survived. Diabetes was present in 5.4{\%} of the patients; heart failure in 6.4{\%}, arrhythmias in 5.0{\%}, thrombosis in 1.1{\%}, hypothyroidism in 11.6{\%}, HIV infection in 1.8{\%}. Hypogonadism was diagnosed in 55{\%} of 578 patients who had reached pubertal age: 83.5{\%} of hypogonadic females and 78.6{\%} of males were receiving substitutive hormonal therapy. In conclusion, the survival of patients with thalassemia major is good and improving, but the prevalence of severe complications is still high.",
author = "Caterina Borgna-Pignatti and Simone Rugolotto and {De Stefano}, Piero and Antonio Piga and {Di Gregorio}, Felicia and Gamberini, {Maria Rita} and Vincenzo Sabato and Caterina Melevendi and Cappellini, {Maria Domenica} and Giuseppe Verlato",
year = "1998",
doi = "10.1111/j.1749-6632.1998.tb10479.x",
language = "English",
volume = "850",
pages = "227--231",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Survival and disease complications in thalassemia major

AU - Borgna-Pignatti, Caterina

AU - Rugolotto, Simone

AU - De Stefano, Piero

AU - Piga, Antonio

AU - Di Gregorio, Felicia

AU - Gamberini, Maria Rita

AU - Sabato, Vincenzo

AU - Melevendi, Caterina

AU - Cappellini, Maria Domenica

AU - Verlato, Giuseppe

PY - 1998

Y1 - 1998

N2 - We studied survival and disease complications in 1146 patients with thalassemia major, born from January 1, 1960 to December 31, 1987. At last follow-up, in March 1997, probability of survival to age 20 years was 89% and to age 25 years was 82% for patients born in the years 1970-1974. Patients who died had a serum ferritin level, measured the year before death, significantly higher than those who survived. Diabetes was present in 5.4% of the patients; heart failure in 6.4%, arrhythmias in 5.0%, thrombosis in 1.1%, hypothyroidism in 11.6%, HIV infection in 1.8%. Hypogonadism was diagnosed in 55% of 578 patients who had reached pubertal age: 83.5% of hypogonadic females and 78.6% of males were receiving substitutive hormonal therapy. In conclusion, the survival of patients with thalassemia major is good and improving, but the prevalence of severe complications is still high.

AB - We studied survival and disease complications in 1146 patients with thalassemia major, born from January 1, 1960 to December 31, 1987. At last follow-up, in March 1997, probability of survival to age 20 years was 89% and to age 25 years was 82% for patients born in the years 1970-1974. Patients who died had a serum ferritin level, measured the year before death, significantly higher than those who survived. Diabetes was present in 5.4% of the patients; heart failure in 6.4%, arrhythmias in 5.0%, thrombosis in 1.1%, hypothyroidism in 11.6%, HIV infection in 1.8%. Hypogonadism was diagnosed in 55% of 578 patients who had reached pubertal age: 83.5% of hypogonadic females and 78.6% of males were receiving substitutive hormonal therapy. In conclusion, the survival of patients with thalassemia major is good and improving, but the prevalence of severe complications is still high.

UR - http://www.scopus.com/inward/record.url?scp=0031876331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031876331&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1998.tb10479.x

DO - 10.1111/j.1749-6632.1998.tb10479.x

M3 - Article

VL - 850

SP - 227

EP - 231

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -